false

Matt Arnold

Strategic, highly collaborative biotechnology industry veteran, driven by opportunities to bring life-changing therapeutics to patients. Over two decades of global, cross-functional biotech and pharmaceutical experience, across both rapid growth and mature organizations, including leadership positions at AVROBIO, AstraZeneca, and Amgen.

• Read: Challenges & Opportunities in Cell and Gene Therapy

  Manufacturing

  Challenges & Opportunities in Cell and Gene Therapy

  Oct 15, ‘24 | 1 min read

  • 

    Anshul Mangal

  Discover
• Read: How European Oncology Site Networks Streamline Clinical Trial Site Selection

  Clinical Trials - Oncology

  How European Oncology Site Networks Streamline Clinical Trial Site Selection

  Oct 14, ‘24 | 6 min read

  • 

    Deana Demjen

  Discover
• Read: Clinical Trial Trends: Early Phase Oncology

  Clinical Trials - Early Phase Research - Oncology

  Clinical Trial Trends: Early Phase Oncology

  Oct 12, ‘24 | 4 min read

  • 

    Natacha Grand

  Discover
• Read: The Dose Dilemma: Lessons from Sotorasib and the Future of Oncology Drug Optimization

  Clinical Trials - Oncology

  The Dose Dilemma: Lessons from Sotorasib and the Future of Oncology Drug Optimization

  Oct 11, ‘24 | 6 min read

  • 

    Harpreet Singh, MD

  Discover
• Read: Why Antibody-Drug Conjugates Are Revolutionizing Precision Oncology

  Clinical Trials - Oncology

  Why Antibody-Drug Conjugates Are Revolutionizing Precision Oncology

  Oct 11, ‘24 | 9 min read

  • 

    Ivan Barrera

  Discover
• Read: Therapeutic Genome Editing – Reshaping the Landscape of Advanced Therapies

  Regulatory - Gene Therapies

  Therapeutic Genome Editing – Reshaping the Landscape of Advanced Therapies

  Oct 10, ‘24 | 2 min read

  • 

    Precision Experts

  Discover
• Read: Clinical Trial Trends: Non-Hodgkin’s Lymphoma

  Clinical Trials - Oncology

  Clinical Trial Trends: Non-Hodgkin’s Lymphoma

  Sep 24, ‘24 | 6 min read

  • 

    Jen Vance

  Discover
• Read: US Crackdown on Chinese Clinical Trials: What’s at Stake for Biopharma?

  Manufacturing

  US Crackdown on Chinese Clinical Trials: What’s at Stake for Biopharma?

  Sep 18, ‘24 | 1 min read

  • 

    Anshul Mangal

  Discover
• Read: Safety isn’t a Milestone but a Mindset in Clinical Research

  Clinical Trials

  Safety isn’t a Milestone but a Mindset in Clinical Research

  Sep 16, ‘24 | 6 min read

  • 

    Renise Blythe

  Discover

Loading...

You've reach the end Back to top